1. Home
  2. RJET vs PHAR Comparison

RJET vs PHAR Comparison

Compare RJET & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RJET

Republic Airways Holdings Inc.

N/A

Current Price

$17.79

Market Cap

930.0M

Sector

N/A

ML Signal

N/A

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.87

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RJET
PHAR
Founded
1982
1988
Country
United States
Netherlands
Employees
8400
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.0M
885.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RJET
PHAR
Price
$17.79
$12.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.33
AVG Volume (30 Days)
181.4K
8.0K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.04
Revenue Next Year
N/A
$2.51
P/E Ratio
$0.21
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$15.37
$9.54
52 Week High
$26.70
$21.34

Technical Indicators

Market Signals
Indicator
RJET
PHAR
Relative Strength Index (RSI) 43.53 46.04
Support Level $17.90 $11.88
Resistance Level $20.65 $13.61
Average True Range (ATR) 1.10 0.48
MACD -0.10 0.13
Stochastic Oscillator 35.47 73.69

Price Performance

Historical Comparison
RJET
PHAR

About RJET Republic Airways Holdings Inc.

Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: